Advertisement
News
Advertisement

Lpath, Inc. CEO to Present Live, Online at RetailInvestorConferences.com on May 5th

Mon, 05/02/2011 - 12:38pm
Bio-Medicine.Org

NEW YORK, May 2, 2011 /PRNewswire/ -- Lpath, Inc. (OTCBB: LPTN), the category leader in bioactive-lipid-targeted therapeutics, today announced that Scott Pancoast, Lpath President and CEO, will present at RetailInvestorConferences.com.DATE:

May 5th, 2011TIME:

3:00 PM EDTLINK:

www.retailinvestorconferences.com>Click the red "register/ watch event now" button.This will be a live, interactive online event where investors are invited to ask the company questions in real-time both in the presentation hall as well as the company's "virtual trade booth." If attendees are not able to join the event live in real-time, an on-demand archive will be available for 90 days.

It is recommended that investors pre-register to save time and receive event updates.

About LpathSan Diego-based Lpath, a therapeutic antibody company, is the category leader in lipidomics-based therapeutics, an emerging field of medicine that targets bioactive signaling lipids for treating a wide range of human disease. Lpath's ImmuneY2(TM) drug-discovery engine has the unique ability to generate therapeutic antibodies that bind to and inhibit bioactive lipids that contribute to disease. The company has developed three drug candidates, two of which -- ASONEP(TM) for cancer and iSONEP(TM) for wet AMD -- have completed Phase 1 clinical trials. Lpath entered into an agreement with Pfizer in 2010 that provides Pfizer an exclusive option for a worldwide license to develop and commercialize iSONEP. For more information, visit www.Lpath.com.

About RetailInvestorConferences.com:RetailInvestorConferences.com, created by BetterInvesting (NAIC), PR Newswire and MUNCmedia, is the first monthly virtual investor conference series that provides an interactive f

'/>"/>

SOURCE

Topics

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading